NovAccess Global Company Insiders

XSNX Stock  USD 0.0001  0.00  0.00%   
NovAccess Global employs about 2 people. The company is managed by 3 executives with a total tenure of roughly 5 years, averaging almost 1.0 years of service per executive, having 0.67 employees per reported executive. Break down of NovAccess Global's management performance can provide insight into the company performance.
MPH MPH  Insider
CEO Director
Neil Laird  Insider
Chief Officer
  
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in NovAccess Global. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

NovAccess Global Management Team Effectiveness

The company has return on total asset (ROA) of (5.1333) % which means that it has lost $5.1333 on every $100 spent on assets. This is way below average. NovAccess Global's management efficiency ratios could be used to measure how well NovAccess Global manages its routine affairs as well as how well it operates its assets and liabilities.
NovAccess Global maintains a total of 19.57 Million outstanding shares. NovAccess Global holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as NovAccess Global in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of NovAccess Global, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

NovAccess Global Workforce Comparison

NovAccess Global is rated below average in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 201. NovAccess Global holds roughly 2.0 in number of employees claiming about 1.0% of stocks in Biotechnology industry.

NovAccess Global Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. NovAccess Global Price Series Summation is a cross summation of NovAccess Global price series and its benchmark/peer.

NovAccess Global Notable Stakeholders

A NovAccess Global stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as NovAccess Global often face trade-offs trying to please all of them. NovAccess Global's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting NovAccess Global's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
MPH MPHCEO DirectorProfile
Neil LairdChief OfficerProfile
Christopher WheelerPres TherapeuticsProfile
String symbol = request.getParameter("s");

About NovAccess Global Management Performance

The success or failure of an entity such as NovAccess Global often depends on how effective the management is. NovAccess Global management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of NovAccess management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the NovAccess management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio. Novaccess Global operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.
Please note, the imprecision that can be found in NovAccess Global's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of NovAccess Global. Check NovAccess Global's Beneish M Score to see the likelihood of NovAccess Global's management manipulating its earnings.

NovAccess Global Workforce Analysis

Traditionally, organizations such as NovAccess Global use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare NovAccess Global within its industry.

NovAccess Global Manpower Efficiency

Return on NovAccess Global Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee858K
Net Loss Per Executive572K

Additional Tools for NovAccess Pink Sheet Analysis

When running NovAccess Global's price analysis, check to measure NovAccess Global's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovAccess Global is operating at the current time. Most of NovAccess Global's value examination focuses on studying past and present price action to predict the probability of NovAccess Global's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovAccess Global's price. Additionally, you may evaluate how the addition of NovAccess Global to your portfolios can decrease your overall portfolio volatility.